An upcoming public meeting of the US Food and Drug Administration’s Science Board could provide direction on evaluating the safety of dietary supplements and food containing cannabinoids or reveal that use of hemp ingredients has moved in directions the agency didn’t anticipate.
In a meeting conducted online on 14 June, the panel of FDA science advisors will use “cannabinoids as a case...